F-group (family)
2006.1.1.14 HAD
Ligands and drugs
143
Member domains
27
with ligand contacts (≤ 4 Å)
18.9% of members
21
with DrugDomain annotations
14.7% of members
8
with a DrugBank compound
5.6% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2006.1.1.14 belongs to X-group 2006 HAD domain-like, which binds 9.7 ligand superclasses per 20 proteins, broader than 91% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00133 | SER | Serine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 20 |
| CL | CHLORIDE ION | 9 |
| CAmetal | CALCIUM ION | 2 |
| NAmetal | SODIUM ION | 2 |
| SER | SERINE | 2 |
| ZNmetal | ZINC ION | 2 |
| E7P | (2S)-2-amino-4-phosphonobutanoic acid | 1 |
| KVU | 1-(2,4-dichlorophenyl)-3-oxidanyl-urea | 1 |
| PG0 | 2-(2-METHOXYETHOXY)ETHANOL | 1 |
| PIM | 4-PHENYL-1H-IMIDAZOLE | 1 |
| SEP | PHOSPHOSERINE | 1 |
| WHT | (2~{R})-2-azanyl-3-phosphono-propanoic acid | 1 |